Ella Ye – Asian Fund for Cancer Research

We Are Hiring! Project Development & Fundraising Manager

October 10, 2025 AFCR News

Project Development & Fundraising Manager Asian Fund for Cancer Research (AFCR) | Hong Kong | Full-Time About AFCR The Asian Fund for Cancer Research (AFCR) is a nonprofit organization advancing innovative cancer research and patient-centered solutions across Asia. AFCR builds collaborative platforms…

Announcing the 2025 USCACA–AFCR Young Investigator Award Recipients

August 13, 2025 AFCR News

We are delighted to honor this year’s exceptional early-career Chinese cancer researchers for their significant achievements in advancing cancer research and drug development. Since 2010, the Asian Fund for Cancer Research and the US Chinese Anti-Cancer Association have jointly presented the USCACA–AFCR…

Screening Recommendations For Common Cancers (2025)

July 9, 2025 AFCR News, Cancer Prevention & Treatments

Regular screenings improve early detection and treatment outcomes. Individuals with a family history, genetic predispositions (e.g., BRCA mutations), or other risk factors should consult their doctors for personalized screening guidance. 1. Breast Cancer Age Group: 40-44: Optional annual mammogram. Women may choose to…

20 Years of Impact: A Snapshot of AFCR-Supported Research

June 18, 2025 AFCR News

AFCR SUPPORTS various types of cancer and stages of research including basic, translational and clinical. As we reach this meaningful twenty-year milestone, we honor the dedication of scientists, donors, and partners who have made these achievements possible. The future holds even greater promise as…

AFCR Statement Regarding Taiwan FactCheck Center’s Article on Vitamin B12 and Cancer

June 5, 2025 AFCR News

The Asian Fund for Cancer Research (AFCR) is committed to supporting groundbreaking cancer research and promoting accurate, science-based health information. In light of recent public discussions and a fact-check article published by the Taiwan FactCheck Center, we wish to clarify AFCR’s position…

Targeted Protein Degradation for Cancer Therapy

May 27, 2025 AFCR News, Current Programs

A Breakthrough Approach to “Undruggable” Targets THE CHALLENGE: Undruggable Targets In Cancer Many cancer-driving proteins remain out of reach for current treatments. These include transcription factors, RNA-binding proteins, and other intracellular regulators that lack suitable binding sites for traditional drugs. Biologic therapies,…

We Are Hiring! Director of Marketing & Business Development

April 18, 2025 AFCR News

Position Overview: The Director of Marketing and Business Development at the Asian Fund for Cancer Research (AFCR) is responsible for driving the foundation’s growth in Hong Kong and the Asia-Pacific region by developing and executing comprehensive marketing strategies, managing strategic partnerships, and…

Celiac Disease and Cancer: What’s the Connection?

April 15, 2025 AFCR News, Awareness

Celiac disease is an immune reaction triggered by consuming gluten, a protein found in wheat, barley, and rye. Research indicates that individuals with celiac disease have a higher risk of developing three types of cancer. WHO IS AFFECTED BY CELIAC DISEASE? Celiac disease…

2024 USCACA-AFCR Young Investigator Award Winners Announced

February 20, 2025 AFCR News

We are proud to recognize this year’s outstanding early-career Chinese cancer researchers for their remarkable contributions to advancing cancer research and drug development. Since 2010, the Asian Fund for Cancer Research and the US Chinese Anti-Cancer Association have jointly presented the USCACA-AFCR…

Snapshot of Cancer Research Progress in 2024

January 15, 2025 AFCR News

NOTABLE RESEARCH HIGHLIGHTS AFCR-supported scientists have made remarkable advances in the fight against cancer. Here are some notable research highlights in 2024 supported by your generous donations. First-in Class Molecular Glue Degraders Dr. Lily Zou’s research is at the forefront of developing a novel…

Author page: Ella Ye